Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078034281> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W2078034281 endingPage "166" @default.
- W2078034281 startingPage "161" @default.
- W2078034281 abstract "Background. Capecitabine is a novel fluoropyrimidine administered orally for treatment of gastrointestinal and breast malignancies. Toxicity described with capecitabine includes hand-and-foot syndrome (HFS), a potentially painful inflammation of the hands and feet. Pyridoxine has been reported to produce improvement in HFS symptoms. We conducted our study to determine the incidence and severity of HFS symptoms in capecitabine patients and to assess the effects of pyridoxine administered as prophylaxis or treatment. Patients and methods. We retrospectively reviewed 99 charts of capecitabine patients receiving pyridoxine and 99 charts of those who had not. Results. Of the 99 pyridoxine patients, 73 (74%) received it as prophylaxis, with the remainder receiving pyridoxine as acute HFS treatment. The median number of capecitabine cycles administered was five, with first-reported HFS onset at cycle 2 in those receiving pyridoxine prophylaxis versus 1.5 in those not (P 5 0.06). Incidence was significantly associated with capecitabine dose, with 76% of patients experiencing HFS in the highest dose ranges compared with 40% in the lowest (P B 0.01). The data did not support that pyridoxine prophylaxis prevented overall HFS incidence in a greater proportion of patients compared with those who did not receive prophylaxis (60% versus 53%, respectively, P 5 NS). However, when used as treatment, a greater proportion of patients receiving pyridoxine reported symptom improvement compared with those not receiving the agent (65% versus 12%, P B0.001). No differences in 12-week tumor response were seen. Conclusion. The data do not support the use of pyridoxine as prophylaxis as neither the incidence nor the severity of HFS was affected. Once HFS develops, however, pyridoxine may provide some relief of HFS symptoms. A controlled trial of capecitabine with and without pyridoxine seems warranted." @default.
- W2078034281 created "2016-06-24" @default.
- W2078034281 creator A5005344580 @default.
- W2078034281 creator A5008536627 @default.
- W2078034281 creator A5050288292 @default.
- W2078034281 creator A5053840418 @default.
- W2078034281 creator A5059565312 @default.
- W2078034281 creator A5068534336 @default.
- W2078034281 date "2003-12-01" @default.
- W2078034281 modified "2023-09-26" @default.
- W2078034281 title "Pyridoxine treatment and prevention of hand-and-foot syndrome in patients receiving capecitabine" @default.
- W2078034281 cites W1811602282 @default.
- W2078034281 cites W1845493768 @default.
- W2078034281 cites W1849818006 @default.
- W2078034281 cites W1910716144 @default.
- W2078034281 cites W1939003096 @default.
- W2078034281 cites W1979186680 @default.
- W2078034281 cites W2022084003 @default.
- W2078034281 cites W2049688682 @default.
- W2078034281 cites W2061500738 @default.
- W2078034281 cites W2064920797 @default.
- W2078034281 cites W2087835174 @default.
- W2078034281 cites W2148809873 @default.
- W2078034281 cites W2396149304 @default.
- W2078034281 cites W4250481919 @default.
- W2078034281 doi "https://doi.org/10.1191/1078155203jp116oa" @default.
- W2078034281 hasPublicationYear "2003" @default.
- W2078034281 type Work @default.
- W2078034281 sameAs 2078034281 @default.
- W2078034281 citedByCount "26" @default.
- W2078034281 countsByYear W20780342812012 @default.
- W2078034281 countsByYear W20780342812013 @default.
- W2078034281 countsByYear W20780342812014 @default.
- W2078034281 countsByYear W20780342812015 @default.
- W2078034281 countsByYear W20780342812018 @default.
- W2078034281 countsByYear W20780342812019 @default.
- W2078034281 countsByYear W20780342812020 @default.
- W2078034281 countsByYear W20780342812021 @default.
- W2078034281 crossrefType "journal-article" @default.
- W2078034281 hasAuthorship W2078034281A5005344580 @default.
- W2078034281 hasAuthorship W2078034281A5008536627 @default.
- W2078034281 hasAuthorship W2078034281A5050288292 @default.
- W2078034281 hasAuthorship W2078034281A5053840418 @default.
- W2078034281 hasAuthorship W2078034281A5059565312 @default.
- W2078034281 hasAuthorship W2078034281A5068534336 @default.
- W2078034281 hasConcept C120665830 @default.
- W2078034281 hasConcept C121332964 @default.
- W2078034281 hasConcept C121608353 @default.
- W2078034281 hasConcept C126322002 @default.
- W2078034281 hasConcept C141071460 @default.
- W2078034281 hasConcept C197934379 @default.
- W2078034281 hasConcept C2776514930 @default.
- W2078034281 hasConcept C2777909004 @default.
- W2078034281 hasConcept C526805850 @default.
- W2078034281 hasConcept C61511704 @default.
- W2078034281 hasConcept C71924100 @default.
- W2078034281 hasConcept C90924648 @default.
- W2078034281 hasConceptScore W2078034281C120665830 @default.
- W2078034281 hasConceptScore W2078034281C121332964 @default.
- W2078034281 hasConceptScore W2078034281C121608353 @default.
- W2078034281 hasConceptScore W2078034281C126322002 @default.
- W2078034281 hasConceptScore W2078034281C141071460 @default.
- W2078034281 hasConceptScore W2078034281C197934379 @default.
- W2078034281 hasConceptScore W2078034281C2776514930 @default.
- W2078034281 hasConceptScore W2078034281C2777909004 @default.
- W2078034281 hasConceptScore W2078034281C526805850 @default.
- W2078034281 hasConceptScore W2078034281C61511704 @default.
- W2078034281 hasConceptScore W2078034281C71924100 @default.
- W2078034281 hasConceptScore W2078034281C90924648 @default.
- W2078034281 hasIssue "4" @default.
- W2078034281 hasLocation W20780342811 @default.
- W2078034281 hasOpenAccess W2078034281 @default.
- W2078034281 hasPrimaryLocation W20780342811 @default.
- W2078034281 hasRelatedWork W1970461912 @default.
- W2078034281 hasRelatedWork W2003938723 @default.
- W2078034281 hasRelatedWork W2047967234 @default.
- W2078034281 hasRelatedWork W2078034281 @default.
- W2078034281 hasRelatedWork W2118496982 @default.
- W2078034281 hasRelatedWork W2275480158 @default.
- W2078034281 hasRelatedWork W2364998975 @default.
- W2078034281 hasRelatedWork W2439875401 @default.
- W2078034281 hasRelatedWork W4238867864 @default.
- W2078034281 hasRelatedWork W2525756941 @default.
- W2078034281 hasVolume "9" @default.
- W2078034281 isParatext "false" @default.
- W2078034281 isRetracted "false" @default.
- W2078034281 magId "2078034281" @default.
- W2078034281 workType "article" @default.